Cargando…

Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria

A main challenge in chemotherapy is to determine the in cellulo parameters modulating the drug concentration required for therapeutic action. It is absolutely urgent to understand membrane permeation and intracellular concentration of antibiotics in clinical isolates: passing the membrane barrier to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allam, Anas, Maigre, Laure, Vergalli, Julia, Dumont, Estelle, Cinquin, Bertrand, Alves de Sousa, Rodolphe, Pajovic, Jelena, Pinet, Elizabeth, Smith, Nikaia, Herbeuval, Jean-Philippe, Réfrégiers, Matthieu, Artaud, Isabelle, Pagès, Jean-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430551/ https://www.ncbi.nlm.nih.gov/pubmed/28428543 http://dx.doi.org/10.1038/s41598-017-00945-8

Ejemplares similares

Fluoroquinolone structure and translocation flux across bacterial membrane
por: Vergalli, Julia, et al.
Publicado: (2017)

Mechanistic aspects of maltotriose-conjugate translocation to the Gram-negative bacteria cytoplasm
por: Dumont, Estelle, et al.
Publicado: (2018)

Microspectrometric insights on the uptake of antibiotics at the single bacterial cell level
por: Cinquin, Bertrand, et al.
Publicado: (2015)

The challenge of intracellular antibiotic accumulation, a function of fluoroquinolone influx versus bacterial efflux
por: Vergalli, Julia, et al.
Publicado: (2020)

Antibiotic Transport in Resistant Bacteria: Synchrotron UV Fluorescence Microscopy to Determine Antibiotic Accumulation with Single Cell Resolution
por: Kaščáková, Slávka, et al.
Publicado: (2012)

A framework for dissecting affinities of multidrug efflux transporter AcrB to fluoroquinolones
por: Vergalli, Julia, et al.
Publicado: (2022)

Characteristics of Plasmacytoid Dendritic Cell and CD4+ T Cell in HIV Elite Controllers
por: Herbeuval, Jean-Philippe, et al.
Publicado: (2012)

An efficient method for gene silencing in human primary plasmacytoid dendritic cells: silencing of the TLR7/IRF-7 pathway as a proof of concept
por: Smith, Nikaïa, et al.
Publicado: (2016)

Rejuvenating the Activity of Usual Antibiotics on Resistant Gram-Negative Bacteria: Recent Issues and Perspectives
por: Tabcheh, Jinane, et al.
Publicado: (2023)

A unique peptide deformylase platform to rationally design and challenge novel active compounds
por: Fieulaine, Sonia, et al.
Publicado: (2016)

Corrigendum: A unique peptide deformylase platform to rationally design and challenge novel active compounds
por: Fieulaine, Sonia, et al.
Publicado: (2017)

In Vivo Evolution of Bacterial Resistance in Two Cases of Enterobacter aerogenes Infections during Treatment with Imipenem
por: Philippe, Nadège, et al.
Publicado: (2015)

Synchrotron multimodal imaging in a whole cell reveals lipid droplet core organization
por: Jamme, Frédéric, et al.
Publicado: (2020)

Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteria
por: DUMLU, Rıdvan, et al.
Publicado: (2022)

New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors
por: Mamelli, Laurent, et al.
Publicado: (2009)

Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis
por: Li, Dan, et al.
Publicado: (2021)

Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons
por: Sinigaglia, Laura, et al.
Publicado: (2018)

2379. Multicenter Evaluation of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
por: Jorgensen, Sarah, et al.
Publicado: (2018)

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Inhaled ceftazidime and amikacin versus inhaled colistin in the treatment of gram negative ventilator associated pneumonia
por: Nassar, YS, et al.
Publicado: (2015)

Permeation of β-Lactamase Inhibitors through the General Porins of Gram-Negative Bacteria
por: Pira, Alessandro, et al.
Publicado: (2020)

Severe ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Picard, Matthieu, et al.
Publicado: (2011)

Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences
por: Criscuolo, Marianna, et al.
Publicado: (2020)

Clinical efficacy and drug resistance of ceftazidime-avibactam in the treatment of Carbapenem-resistant gram-negative bacilli infection
por: Xiao, Shuang, et al.
Publicado: (2023)

Ceftazidime-Avibactam for Carbapenem-Resistant Gram-Negative Bacteria Infections: A Real-World Experience in the ICU
por: Yu, Jiaxin, et al.
Publicado: (2023)

An Intertwined Network of Regulation Controls Membrane Permeability Including Drug Influx and Efflux in Enterobacteriaceae
por: Ferrand, Aurélie, et al.
Publicado: (2020)

Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021)

Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)

Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections
por: Lagacé-Wiens, Philippe, et al.
Publicado: (2014)

Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria
por: Gonzalez, Mark D., et al.
Publicado: (2017)

Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review
por: Soriano, Alex, et al.
Publicado: (2021)

Early and Appropriate Use of Ceftazidime-Avibactam in the Management of Multidrug-Resistant Gram-Negative Bacterial Infections in the Indian Scenario
por: Swaminathan, Subramanian, et al.
Publicado: (2022)

Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection
por: Zheng, Zihao, et al.
Publicado: (2023)

Ceftazidime-Resistant Salmonella enterica, Morocco
por: Bouchrif, Brahim, et al.
Publicado: (2009)

Multiparametric Profiling for Identification of Chemosensitizers against Gram-Negative Bacteria
por: Lôme, Vincent, et al.
Publicado: (2018)

616. Evaluation of In Vitro Susceptibility to Ceftazidime/Avibactam of Clinical Isolates of Carbapenem Nonsusceptible Gram-Negative Bacilli from Colombia
por: Appel, Tobias M, et al.
Publicado: (2019)

Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms
por: Khan, Ayesha, et al.
Publicado: (2021)

1278. Testing the Synergistic Effect of Ceftazidime-Avibactam Plus Aztreonam on Metallobetalactamase-Producing Non-Fermenting Gram-negative Bacteria
por: Crouch, Elena M, et al.
Publicado: (2021)

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing
por: Gaibani, Paolo, et al.
Publicado: (2022)

Guanidinylated Polymyxins as Outer Membrane Permeabilizers Capable of Potentiating Rifampicin, Erythromycin, Ceftazidime and Aztreonam against Gram-Negative Bacteria
por: Ramirez, Danzel Marie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5b71sg3m5jbbd5h422hrp3jp8s